A Phase II Study of High Dose Estradiol in Metastatic Triple Negative Breast Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Estradiol (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
Most Recent Events
- 09 Dec 2019 Biomarkers information updated
- 17 Jan 2013 Planned End Date changed from 1 Mar 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 15 Feb 2012 Planned end date changed from 1 Jan 2012 to 1 Mar 2012 as reported by ClinicalTrials.gov.